These substitute drugs, taken by tens of millions, have from time to time been prescribed by health-related professionals via telehealth businesses, boosting issues about a lack of continuity of care and a change from a affected individual’s Principal treatment doctor. (In current weeks, the FDA has taken methods to efficiently ban these copycat